RESEARCHER PROFILE

Ruud Delwel

← Back to Oncode Institute

R

Oncode Institute

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processesChromatin Remodeling and CancerEpigenetics and DNA MethylationHematopoietic Stem Cell Transplantation

Ruud Delwel works in Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, Chromatin Remodeling and Cancer, Epigenetics and DNA Methylation, Hematopoietic Stem Cell Transplantation. Recorded institutional associations include Oncode Institute, Erasmus MC Cancer Institute.

330Publications
20,676Citations
67H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation

    2010 · 2,756 citations
  2. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

    2011 · 1,503 citations
  3. Prognostically Useful Gene-Expression Profiles in Acute Myeloid Leukemia

    2004 · 1,372 citations
  4. DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia

    2010 · 833 citations
  5. A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia

    2014 · 684 citations
  6. Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance

    2005 · 618 citations
  7. Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

    2009 · 566 citations
  8. Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia

    2016 · 387 citations
  9. Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity

    2010 · 384 citations
  10. The Oncogenic MicroRNA miR-22 Targets the TET2 Tumor Suppressor to Promote Hematopoietic Stem Cell Self-Renewal and Transformation

    2013 · 326 citations
  11. Base-Pair Resolution DNA Methylation Sequencing Reveals Profoundly Divergent Epigenetic Landscapes in Acute Myeloid Leukemia

    2012 · 295 citations
  12. Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia

    2015 · 292 citations
  13. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated

    2008 · 280 citations
  14. Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

    2015 · 277 citations
  15. Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation

    2019 · 270 citations
  16. Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia

    2012 · 262 citations
  17. High EVI1 Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities

    2010 · 256 citations
  18. Clinical, Molecular, and Prognostic Significance of WHO Type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and Various Other 3q Abnormalities in Acute Myeloid Leukemia

    2010 · 256 citations
  19. Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia

    2006 · 238 citations
  20. Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML

    2003 · 235 citations
  21. Erratum: Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia

    2015 · 207 citations
  22. Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study

    2013 · 206 citations
  23. Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1

    2007 · 199 citations
  24. Subtype-specific regulatory network rewiring in acute myeloid leukemia

    2018 · 185 citations
  25. Essential role of Jun family transcription factors in PU.1 knockdown–induced leukemic stem cells

    2006 · 183 citations

← Return to the university profile